Inactive Instrument
Genomic Vision Share Price
Stocks
GV
FR0011799907
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Aaron Bensimon
CEO | Chief Executive Officer | - | 01/01/2006 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -10.00% | - | - | 7L | |
| -0.62% | +0.50% | +33.92% | +60.07% | 6.44TCr | |
| +0.35% | +3.04% | +12.64% | +83.62% | 5.62TCr | |
| +0.53% | +2.55% | +13.90% | +104.77% | 5.42TCr | |
| -2.81% | -4.31% | +23.50% | +50.90% | 4.53TCr | |
| -0.33% | -1.93% | +20.15% | +98.45% | 4.22TCr | |
| +0.55% | +2.31% | +224.97% | +942.56% | 4.08TCr | |
| +3.27% | +47.40% | +110.44% | +94.92% | 3.38TCr | |
| +1.22% | -1.39% | +13.92% | +46.95% | 3.22TCr | |
| -1.29% | -1.72% | +21.00% | -6.85% | 2.36TCr | |
| Average | +0.08% | +4.72% | +52.71% | +163.93% | 4.36TCr | |
| Weighted average by Cap. | +0.01% | +3.64% | +49.44% | +162.23% |
Employees
33
